I saw the news recently that the Food and Drug Administration is proposing to remove a popular ingredient in over-the-counter ...
The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.
The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression.